Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1965 Jun;41(476):313–324. doi: 10.1136/pgmj.41.476.313

Some Biochemical Aspects of the Myopathies

B P Hughes
PMCID: PMC2483022  PMID: 21313710

Full text

PDF
313

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDRES R., CADER G., ZIERLER K. L. The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state; measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. J Clin Invest. 1956 Jun;35(6):671–682. doi: 10.1172/JCI103324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BAKER R. W., EVANS J. H. Serum aldolase and the diagnosis of myopathy. Brain. 1957 Dec;80(4):557–570. doi: 10.1093/brain/80.4.557. [DOI] [PubMed] [Google Scholar]
  3. BRODY I. A. THE SIGNIFICANCE OF LACTATE DEHYDROGENASE ISOZYMES IN ABNORMAL HUMAN SKELETAL MUSCLE. Neurology. 1964 Dec;14:1091–1100. doi: 10.1212/wnl.14.12.1091. [DOI] [PubMed] [Google Scholar]
  4. DAWSON D. M., GOODFRIEND T. L., KAPLAN N. O. LACTIC DEHYDROGENASES: FUNCTIONS OF THE TWO TYPES RATES OF SYNTHESIS OF THE TWO MAJOR FORMS CAN BE CORRELATED WITH METABOLIC DIFFERENTIATION. Science. 1964 Feb 28;143(3609):929–933. doi: 10.1126/science.143.3609.929. [DOI] [PubMed] [Google Scholar]
  5. DE MORAGAS J. M., PERRY H. O., FLEISHER G. A. Serum glutamic oxalacetic transaminase in dermatomyositis. J Am Med Assoc. 1957 Dec 14;165(15):1936–1938. doi: 10.1001/jama.1957.02980330038009. [DOI] [PubMed] [Google Scholar]
  6. DEMOS J., DREYFUS J. C., SCHAPIRA F., SCHAPIRA G. Activités enzymatiques du muscle humain; recherches sur la biochimie comparée de l'homme normal et myopathique, et du rat. Clin Chim Acta. 1956 Sep-Oct;1(5):434–449. doi: 10.1016/0009-8981(56)90016-x. [DOI] [PubMed] [Google Scholar]
  7. DREYFUS J. C., SCHAPIRA G., SCHAPIRA F. Serum enzymes in the physiopathology of muscle. Ann N Y Acad Sci. 1958 Oct 13;75(1):235–249. doi: 10.1111/j.1749-6632.1958.tb36870.x. [DOI] [PubMed] [Google Scholar]
  8. DUBOWITZ V., PEARSE A. G. A comparative histochemical study of oxidative enzyme and phosphorylase activity in skeletal muscle. Z Zellforch Microsk Anat Histochem. 1960;2:105–117. doi: 10.1007/BF00744575. [DOI] [PubMed] [Google Scholar]
  9. DUBOWITZ V. Progressive muscular dystrophy of the Duchenne type in females and its mode of inheritance. Brain. 1960 Sep;83:432–439. doi: 10.1093/brain/83.3.432. [DOI] [PubMed] [Google Scholar]
  10. EMERY A. E. ELECTROPHORETIC PATTERN OF LACTIC DEHYDROGENASE IN CARRIERS AND PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY. Nature. 1964 Mar 7;201:1044–1045. doi: 10.1038/2011044a0. [DOI] [PubMed] [Google Scholar]
  11. FOWLER W. M., Jr, CHOWDHURY S. R., PEARSON C. M., GARDNER G., BRATTON R. Changes in serum enzyme levels after exercise in trained and untrained subjects. J Appl Physiol. 1962 Nov;17:943–946. doi: 10.1152/jappl.1962.17.6.943. [DOI] [PubMed] [Google Scholar]
  12. FOWLER W. M., Jr, PEARSON C. M. DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF SERUM ENZYMES. II. NEUROLOGIC DISEASES OTHER THAN MUSCULAR DYSTROPHY. Arch Phys Med Rehabil. 1964 Mar;45:125–130. [PubMed] [Google Scholar]
  13. FRIEDMAN M. M., LAPAN B. Serum aldolase in the neonatal period: including a colorimetric determination of aldolase by standardization with dihydroxyacetone. J Lab Clin Med. 1958 May;51(5):745–752. [PubMed] [Google Scholar]
  14. FRITZ I. B., DAVIS D. G., HOLTROP R. H., DUNDEE H. Fatty acid oxidation by skeletal muscle during rest and activity. Am J Physiol. 1958 Aug;194(2):379–386. doi: 10.1152/ajplegacy.1958.194.2.379. [DOI] [PubMed] [Google Scholar]
  15. GRIFFITHS P. D. Creatinephosphokinase levels in hypothyroidism. Lancet. 1963 Apr 20;1(7286):894–894. doi: 10.1016/s0140-6736(63)91676-3. [DOI] [PubMed] [Google Scholar]
  16. HALONEN P. I., KONTTINEN A. Effect of physical exercise on some enzymes in the serum. Nature. 1962 Mar 10;193:942–944. doi: 10.1038/193942a0. [DOI] [PubMed] [Google Scholar]
  17. HOCKADAY T. D., DOWNEY J. A., MOTTRAM R. F. A CASE OF MCARDLE'S SYNDROME WITH A POSITIVE FAMILY HISTORY. J Neurol Neurosurg Psychiatry. 1964 Jun;27:186–197. doi: 10.1136/jnnp.27.3.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. HUGHES B. P. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta. 1962 Sep;7:597–603. doi: 10.1016/0009-8981(62)90137-7. [DOI] [PubMed] [Google Scholar]
  19. HUGHES B. P. Serum enzyme changes in muscle disease and their relation to tissue change. Proc R Soc Med. 1963 Mar;56:179–182. doi: 10.1177/003591576305600318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. LYON M. F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature. 1961 Apr 22;190:372–373. doi: 10.1038/190372a0. [DOI] [PubMed] [Google Scholar]
  21. Larner J., Villar-Palasi C. ENZYMES IN A GLYCOGEN STORAGE MYOPATHY. Proc Natl Acad Sci U S A. 1959 Aug;45(8):1234–1235. doi: 10.1073/pnas.45.8.1234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. MELLICK R. S., MAHLER R. F., HUGHES B. P. McArdle's syndrome: phosphorylase-deficient myopathy. Lancet. 1962 May 19;1(7238):1045–1048. doi: 10.1016/s0140-6736(62)92145-1. [DOI] [PubMed] [Google Scholar]
  23. Mommaerts W. F., Illingworth B., Pearson C. M., Guillory R. J., Seraydarian K. A FUNCTIONAL DISORDER OF MUSCLE ASSOCIATED WITH THE ABSENCE OF PHOSPHORYLASE. Proc Natl Acad Sci U S A. 1959 Jun;45(6):791–797. doi: 10.1073/pnas.45.6.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. PEARSON C. M. THE PERIODIC PARALYSES: DIFFERENTIAL FEATURES AND PATHOLOGICAL OBSERVATIONS IN PERMANENT MYOPATHIC WEAKNESS. Brain. 1964 Jun;87:341–354. doi: 10.1093/brain/87.2.341. [DOI] [PubMed] [Google Scholar]
  25. PLUMMER D. T., ELLIOTT B. A., COOKE K. B., WILKINSON J. H. Organ specificity and lactate-dehydrogenase activity. 1. The relative activities with pyruvate and 2-oxobutyrate of electrophoretically separated fractions. Biochem J. 1963 May;87:416–422. doi: 10.1042/bj0870416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. ROWLAND L. P., FAHN S., SCHOTLAND D. L. MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE. Arch Neurol. 1963 Oct;9:325–342. doi: 10.1001/archneur.1963.00460100013001. [DOI] [PubMed] [Google Scholar]
  27. Richterich R., Rosin S., Aebi U., Rossi E. Progressive Muscular Dystrophy. V. The Identification of the Carrier State in the Duchenne Type by Serum Creatine Kinase Determination. Am J Hum Genet. 1963 Jun;15(2):133–154. [PMC free article] [PubMed] [Google Scholar]
  28. SCHLANG H. A. The effect of physical exercise on serum transaminase. Am J Med Sci. 1961 Sep;242:338–341. doi: 10.1097/00000441-196109000-00009. [DOI] [PubMed] [Google Scholar]
  29. SCHMID R., HAMMAKER L. Hereditary absence of muscle phosphorylase (McArdle's syndrome). N Engl J Med. 1961 Feb 2;264:223–225. doi: 10.1056/NEJM196102022640504. [DOI] [PubMed] [Google Scholar]
  30. SCHMID R., MAHLER R. Chronic progressive myopathy with myoglobinuria: demonstration of a glycogenolytic defect in the muscle. J Clin Invest. 1959 Nov;38:2044–2058. doi: 10.1172/JCI103983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. SIBLEY J. A., LEHNINGER A. L. Aldolase in the serum and tissue of tumor-bearing animals. J Natl Cancer Inst. 1949 Feb;9(4):303–309. [PubMed] [Google Scholar]
  32. SOLVONUK P. F., MCRAE S. C., COLLIER H. B. Creatine phosphokinase activity of mammalian erythrocytes. Can J Biochem Physiol. 1956 May;34(3):481–487. [PubMed] [Google Scholar]
  33. SUTHERLAND E. W., WOSILAIT W. D. The relationship of epinephrine and glucagon to liver phosphorylase. I. Liver phosphorylase; preparation and properties. J Biol Chem. 1956 Jan;218(1):459–468. [PubMed] [Google Scholar]
  34. THOMPSON R. A., VIGNOS P. J., Jr Serum aldolase in muscle disease. AMA Arch Intern Med. 1959 Apr;103(4):551–564. doi: 10.1001/archinte.1959.00270040037004. [DOI] [PubMed] [Google Scholar]
  35. THOMSON W. A. Sources of error in the biochemical diagnosis of muscular dystrophy. J Neurol Neurosurg Psychiatry. 1962 Aug;25:191–202. doi: 10.1136/jnnp.25.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. THOMSON W. H., LEYBURN P., WALTON J. N. Serum enzyme activity in muscular dystrophy. Br Med J. 1960 Oct 29;2(5208):1276–1281. doi: 10.1136/bmj.2.5208.1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. VAN PILSUM J. F., WOLIN E. A. Guanidinium compounds in blood and urine of patients suffering from muscle disorders. J Lab Clin Med. 1958 Feb;51(2):219–223. [PubMed] [Google Scholar]
  38. VIGNOS P. J., Jr, LEFKOWITZ M. A biochemical study of certain skeletal muscle constituents in human progressive muscular dystrophy. J Clin Invest. 1959 Jun;38(6):873–881. doi: 10.1172/JCI103869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. WILSON K. M., EVANS K. A., CARTER C. O. CREATINE KINASE LEVELS IN WOMEN WHO CARRY GENES FOR THREE TYPES OF MUSCULAR DYSTROPHY. Br Med J. 1965 Mar 20;1(5437):750–753. doi: 10.1136/bmj.1.5437.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. ZIERLER K. L. Increased muscle permeability to aldolase produced by depolarization and by metabolic inhibitors. Am J Physiol. 1958 Jun;193(3):534–538. doi: 10.1152/ajplegacy.1958.193.3.534. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES